HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mislabeled Nail Polishes Warrant Increased Regulation – California DTSC

This article was originally published in The Rose Sheet

Executive Summary

California’s DTSC takes issue with nail polish brands that erroneously claim to be free of toluene, dibutyl phthalate and formaldehyde, calling its review a “wakeup call for greater transparency.” The PBA’s Nail Manufacturers Council does not dispute or disagree with the testing results, but “strongly objects to the report’s lack of perspective and balance.”

You may also be interested in...



Nail Polish Study Making Waves; Will California’s DTSC Be Swept Up?

Nail care remains a category of interest for the Department of Toxic Substances Control under California’s Safer Consumer Products regulation, which targets chemicals for alternatives analysis and potential elimination. DTSC could see the new study as strengthening the case for action in this area.

Nail Polishes Contain Undeclared DEHP, Among Other ‘Regrettable Substitutions’ – Study

A study led by Harvard public health researchers explores a multipart question: If dibutyl phthalate has been phased out of nail polishes, what plasticizers are replacing the ingredient, are they labeled or otherwise declared, and are they any safer than DBP?

Global Corporate Insurer Projects Increased Liability For ‘Toxic Trio’ Use In Cosmetics

Allianz Global Corporate and Specialty raises liability concerns that could be relevant to cosmetics manufacturers still using “toxic trio” ingredients. The firm’s report is a signal at least that rampant US litigation for alleged false advertising and undeclared ingredient risks has reached the international insurance consciousness.

Related Content

Topics

UsernamePublicRestriction

Register

RS018054

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel